1.
PEREIRA ES, SOUZA RA, SFORSIN AP, PINTO VB. Assessment of the Economic Impact of Warfarin Substitution with Rivaroxaban. J Hosp Pharm Health Serv [Internet]. 2026 Apr. 7 [cited 2026 Apr. 15];17(1):e1311. Available from: https://jhphs.org/sbrafh/article/view/1311